Utah lawmakers will consider a proposal to establish a pilot program allowing sleep-related conditions to qualify for medical marijuana, along with potential changes to restrictions on telehealth recommendations, during a legislative meeting scheduled for today, October 19.
According to the official meeting agenda, the state’s Medical Cannabis Governance Structure Working Group will examine the existing list of qualifying conditions, the role of the Compassionate Use Board and a proposal to allow sleep to serve as a qualifying condition through a pilot program. The meeting is scheduled for 3:30 p.m. Mountain Time at the Utah State Capitol complex.
Under current Utah law, patients must generally have a qualifying condition such as chronic pain, cancer, epilepsy, post-traumatic stress disorder or multiple sclerosis to obtain a medical marijuana recommendation. Sleep disorders, including insomnia, are not independently included on the statutory list. However, patients with conditions not specifically recognized under state law can petition the Compassionate Use Board, which reviews requests individually.
Lawmakers will also review Utah’s restrictions on virtual medical marijuana appointments. State law generally requires patients to meet with a medical provider in person before receiving an initial recommendation, although exceptions exist for terminally ill patients, those receiving hospice care and residents of certain long-term care facilities. Virtual appointments are also allowed for patients who have previously met face-to-face with their recommending provider.
The working group will consider whether changes to those requirements are appropriate, potentially opening the door to broader telehealth access for medical marijuana patients.
Several additional marijuana policy issues are scheduled for discussion, including whether terminally ill patients should be allowed to use medical marijuana in hospitals and other healthcare facilities. Lawmakers will also examine concerns about out-of-state marijuana businesses advertising products in Utah that are not legal under the state’s existing program.
Other agenda items include an update on implementing a new marijuana inventory tracking system, integrating medical marijuana dispensing information into Utah’s controlled substance database and reviewing the potential effects of federal marijuana rescheduling on the state’s medical program.
The working group, which includes members of both legislative chambers, is responsible for examining Utah’s medical marijuana regulatory structure and developing policy recommendations for lawmakers.
